Oxford pauses to test AstraZeneca of children

Oxford University has stopped giving children and teenagers a vaccine developed with AstraZeneca as part of a study, pending more information on cases of blood clotting reported after the vaccine, the Wall Street Journal reported on Tuesday. The European Bars Agency EMA is investigating 44 reports of extreme cases [...]
The European Bars Agency EMA is investigating 44 reports of extremely rare cases of brain clotting, known as vibrous sinus cebral (CVST) and is expected to release its findings on Wednesday or Thursday.
An EMA official said earlier today that there was a <x0 connection” clear between the British-Swedish Company's vaccine and CVST, but that the real cause was not yet known.
Oxford will wait for additional information from the drug regulator in Great Britain before continuing to give children and teenagers vaccines as part of the research, a university spokesman for the Wall Street Journal said.











